Before the vaccine, rotavirus caused an estimated 24 million outpatient visits, 2.4 million hospitalizations, and 453,000 deaths in infants and young children worldwide each year. Following the introduction of the pediatric rotavirus vaccine in the United States, declines in the disease have been seen in both vaccinated and unvaccinated children.
Evan J. Anderson, MD, now at Emory University, and a team of researchers at Northwestern Memorial and Children's Memorial Hospitals in Chicago looked into whether the vaccine's benefits extended to unvaccinated adults. They compared the prevalence and genotypes of rotavirus in stool samples collected from approximately 3,500 adults before widespread implementation of pediatric rotavirus vaccination (2006-2007) with the prevalence in samples collected from 2008 to 2010. The researchers found the number of unvaccinated adults who had rotavirus was almost halved in the years after the vaccine was introduced for use in children in the U.S.
"In adults with diarrhea who see the doctor and who have testing for bacterial infections, we noticed an almost 50 percent decrease in rotavirus," said Dr. Anderson. With previous research estimating $152 million in total adult inpatient hospital charges related to rotavirus each year in the U.S., this latest data may make pediatric vaccination "much more cost effective than previously believed."
Dramatic declines in rotavirus prevalence were evident in both adults admitted to the hospital and in those treated as outpatients. The findings suggest that "vaccinating children can protect adults from rotavirus by decreasing the amount of rotavirus circulating in the community," Dr. Anderson said. Because rotavirus genotypes change from year to year, the researchers also noted that "ongoing surveillance is needed to determine whether this impact is sustained."
The positive effect of pediatric rotavirus vaccination programs on the prevalence of disease among both young and old, vaccinated or not, underscores the need to support and encourage vaccination, Dr. Anderson said. "By improving the health of children, we indirectly improve the health of adults."
The study is available online. It is embargoed until 12:01 a.m. EST on Thursday, Jan. 24, 2013:
Clinical Infectious Diseases is a leading journal in the field of infectious disease with a broad international readership. The journal publishes articles on a variety of subjects of interest to practitioners and researchers. Topics range from clinical descriptions of infections, public health, microbiology, and immunology to the prevention of infection, the evaluation of current and novel treatments, and the promotion of optimal practices for diagnosis and treatment. The journal publishes original research, editorial commentaries, review articles, and practice guidelines and is among the most highly cited journals in the field of infectious diseases. Clinical Infectious Diseases is an official publication of the Infectious Diseases Society of America (IDSA). Based in Arlington, Va., IDSA is a professional society representing nearly 10,000 physicians and scientists who specialize in infectious diseases.
Jerica Pitts | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine